Targeting p35/Cdk5 Signalling via CIP-Peptide Promotes Angiogenesis in Hypoxia
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting p35/Cdk5 Signalling via CIP-Peptide Promotes Angiogenesis in Hypoxia
Authors
Keywords
Angiogenesis, Hypoxia, Cell migration, Actins, Integrins, Neuronal death, Small interfering RNAs, Cytoskeleton
Journal
PLoS One
Volume 8, Issue 9, Pages e75538
Publisher
Public Library of Science (PLoS)
Online
2013-10-01
DOI
10.1371/journal.pone.0075538
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibition of calpain-regulated p35/cdk5 plays a central role in sildenafil-induced protection against chemical hypoxia produced by malonate
- (2013) Lucía Barros-Miñones et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Cyclin-dependent kinase 5 regulates E2F transcription factor through phosphorylation of Rb protein in neurons
- (2012) Akira Futatsugi et al. CELL CYCLE
- Cyclin-Dependent Kinase Inhibition With Roscovitine: Neuroprotection in Acute Ischemic Stroke
- (2012) S Timsit et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Opticin Exerts Its Anti-angiogenic Activity by Regulating Extracellular Matrix Adhesiveness
- (2012) Magali M. Le Goff et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The protective effects of tanshinone IIA on neurotoxicity induced by β-amyloid protein through calpain and the p35/Cdk5 pathway in primary cortical neurons
- (2012) Li-Li Shi et al. NEUROCHEMISTRY INTERNATIONAL
- Going out of the brain: Non-nervous system physiological and pathological functions of Cdk5
- (2011) Erick Contreras-Vallejos et al. CELLULAR SIGNALLING
- The liquid overlay technique is the key to formation of co-culture spheroids consisting of primary osteoblasts, fibroblasts and endothelial cells
- (2011) Wolfgang Metzger et al. CYTOTHERAPY
- Histone deacetylase inhibitors enhance endothelial cell sprouting angiogenesis in vitro
- (2011) Guang Jin et al. SURGERY
- Anti-angiogenic potential of small molecular inhibitors of cyclin dependent kinases in vitro
- (2010) Stefan Zahler et al. ANGIOGENESIS
- Cdk5 interacts with Hif-1α in neurons: A new hypoxic signalling mechanism?
- (2010) Xanthi Antoniou et al. BRAIN RESEARCH
- The neuronal p35 activator of Cdk5 is a novel F-actin binding and bundling protein
- (2010) Lisheng He et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Cyclin-dependent Kinase 5 Regulates Endothelial Cell Migration and Angiogenesis
- (2010) Johanna Liebl et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Brassica Exon Array for Whole-Transcript Gene Expression Profiling
- (2010) Christopher G. Love et al. PLoS One
- Evaluation of Soluble Junctional Adhesion Molecule-A as a Biomarker of Human Brain Endothelial Barrier Breakdown
- (2010) Axel Haarmann et al. PLoS One
- Targeting Cdk5 Activity in Neuronal Degeneration and Regeneration
- (2009) Jyotshnabala Kanungo et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Pharmacodynamic Effects of Seliciclib, an Orally Administered Cell Cycle Modulator, in Undifferentiated Nasopharyngeal Cancer
- (2009) W.-S. Hsieh et al. CLINICAL CANCER RESEARCH
- Essential Role of Cytoplasmic cdk5 and Prx2 in Multiple Ischemic Injury Models, In Vivo
- (2009) J. Rashidian et al. JOURNAL OF NEUROSCIENCE
- Talin phosphorylation by Cdk5 regulates Smurf1-mediated talin head ubiquitylation and cell migration
- (2009) Cai Huang et al. NATURE CELL BIOLOGY
- Cyclin-dependent kinase-5 targeting for ischaemic stroke
- (2008) Mark Slevin et al. CURRENT OPINION IN PHARMACOLOGY
- Distinct functions of Cdk5(Y15) phosphorylation and Cdk5 activity in stress fiber formation and organization
- (2008) Fengyu Qiao et al. EXPERIMENTAL CELL RESEARCH
- Roscovitine up-regulates p53 protein and induces apoptosis in human HeLaS3cervix carcinoma cells
- (2008) Józefa Węsierska-Gądek et al. JOURNAL OF CELLULAR BIOCHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started